RESEARCH-USE BIOSIMILAR ANTIBODY
Mogamulizumab
Monoclonal antibody · IgG1
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL).
TARGETCCR4
YMonoclonal antibody
TARGETCCR4
CATALOG NUMBERSC-BS-361
MOLECULAR WEIGHTApprox. 146.44 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL).
Mogamulizumab is a recombinant research-use antibody directed against CCR4 / CCR4.